Psoas Compartment Block Versus Fascia Iliaca Block After Total Hip Arthroplasty

NCT01378949 | Unknown DMC

• 1 other identifier: 2259-11-HYMC
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

A psoas compartment block has been used with good results for postoperative pain relief after total hip arthroplasty (THA). However, case reports describing serious complications after the use of this block, have been reported. The fascia iliaca compartment block (FICB) has been shown to be a reliable block for postoperative pain relief for procedures and injuries involving the hip. The investigators have not found any literature that has compared these two blocks. This study will compare the two blocks when used for post-operative pain relief after THA.

Conditions

Pain

Keywords

pain score

Outcome Measures

Primary Outcomes (1)

• Pain score of patients who have been given FICB for post-operative pain relief after THA

  3 days

Study Arms (3)

PsCB Group

ACTIVE COMPARATOR

Ultrasound-Guided Psoas Compartment Block will be used in patients for pain relief after THA

Drug: Bupivacaine

FICB Group

ACTIVE COMPARATOR

Ultrasound-Guided Fascia Iliaca Compartment Block will be used in patients for pain relief after THA

Drug: Bupivacaine

Patient-Controlled Analgesia

ACTIVE COMPARATOR

Patient-controlled analgesia will be used for pain relief after THA

Drug: Morphine

Interventions

Bupivacaine DRUG

Bupivacaine 0.5% with adrenaline 5 mcg/cc

FICB Group; PsCB Group

Morphine DRUG

Morphine 1 mg/cc

Patient-Controlled Analgesia

Eligibility Criteria

• Age: 45 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• ASA Class I-III
• Patients undergoing THA for osteoarthritis

You may not qualify if:

• Skin infections adjacent to block site
• Allergy to local analgesics
• Patient unable to understand visual analogue scale (VAS)

Sponsors & Collaborators

• Hillel Yaffe Medical Center: lead

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

Location

MeSH Terms

Conditions

Pain

Interventions

Bupivacaine; Morphine

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines; Morphine Derivatives; Morphinans; Opiate Alkaloids; Alkaloids; Heterocyclic Compounds; Heterocyclic Compounds, Bridged-Ring; Heterocyclic Compounds, 4 or More Rings; Heterocyclic Compounds, Fused-Ring; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Polycyclic Compounds

Central Study Contacts

Anatoly Stav, MD

CONTACT

972-4-630-4529; stav@hy.health.gov.il

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV

Study Record Dates

• First Submitted: June 19, 2011
• First Posted: June 23, 2011
• Study Start: September 1, 2011
• Primary Completion: September 1, 2013
• Study Completion: September 1, 2013
• Last Updated: June 23, 2011

Record last verified: 2011-06

Locations

IL (1)